A Multicenter, Randomized, Double-blind, Two-way Cross-over Study to Compare the Adhesiveness of Two Different Rotigotine Patch Formulations in Subjects With Parkinson's Disease.
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Pharmacodynamics
- Sponsors UCB
- 18 May 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 18 May 2011 New source identified and integrated (United Kingdom Clinical Research Network).
- 26 Apr 2011 New trial record